Snapshot from Aug 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / ClearPoint Neuro Q2 2026 Earnings Release
Business earnings release

ClearPoint Neuro Q2 2026 Earnings Release

Analysis based on 6 articles · First reported Jul 21, 2026 · Last updated Jul 21, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement is a routine earnings release schedule with no immediate market impact. Investors will await the actual results on August 3 for potential stock movement.

Medical Devices Biotechnology
Event Summary

ClearPoint Neuro, Inc. announced it will release its 2026 second quarter financial results on August 3, 2026, after market close. The company will host a conference call at 4:30 p.m. Eastern time to discuss the results. ClearPoint Neuro is a device, cell, and gene therapy-enabling company specializing in precise navigation to the brain and spine. The company's products include the FDA-cleared and CE-marked ClearPoint Neuro Navigation System. It partners with pharmaceutical and biotech companies for central nervous system therapeutics delivery.

Key Actions
50 ClearPoint Neuro announced earnings release
Entities Involved
stock
ClearPoint Neuro
ClearPoint Neuro is the subject of the event, announcing its Q2 2026 earnings release date. The event itself is neutral, but the upcoming results may affect its stock price.
Importance 100.0 Sentiment 0.0
exch
Nasdaq
Nasdaq is the stock exchange where ClearPoint Neuro is listed (ticker CLPT). The event has no direct impact on Nasdaq.
Importance 10.0 Sentiment 0.0
per
Danilo D Alessandro
Danilo D Alessandro is the Chief Financial Officer of ClearPoint Neuro and the contact for investor relations. He is mentioned as a point of contact but not directly impacted.
Importance 10.0 Sentiment 0.0
cnt
Canada
Canada is mentioned as a country from which callers may dial in. The event has no direct impact on Canada.
Importance 5.0 Sentiment 0.0
cnt
United States
The United States is the home country of ClearPoint Neuro and the primary market for its operations. The event has no direct impact on the country.
Importance 5.0 Sentiment 0.0
Relationships
Nasdaq related ↔ United States
Canada trade rivals ↔ United States Canada views the United States as a strained partner and trade rival, facing significant tariffs and renegotiation of tr
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.